Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 April, 2024 10:35 IST
Keryx Biopharmaceuticals fourth-quarter loss narrows on a YOY basis
Source: IRIS | 01 Mar, 2017, 08.10PM

Powered by IRIS XBRL Data
Rating: NAN / 5 stars.
Comments  |  Post Comment

 

Keryx Biopharmaceuticals (KERX) saw its loss narrow to $33.78 million, or $0.32 a share for the quarter ended Dec. 31, 2016. In the previous year period, the company reported a loss of $37.78 million, or $0.36 a share.

Revenue during the quarter surged 64.85 percent to $9.53 million from $5.78 million in the previous year period. Gross margin for the quarter stood at negative 49.17 percent as compared to a positive 70.90 percent for the previous year period.

Operating loss for the quarter was $33.91 million, compared with an operating loss of $25.45 million in the previous year period.

"We are off to a very good start in 2017 with Auryxia in the dialysis patient population," said Greg Madison, president and chief executive officer of Keryx. "During a period when the phosphate binder market declined, Auryxia prescriptions grew to approximately 4,650 in January, an increase of 3.3 percent from the approximate 4,500 prescriptions reported in December 2016."

Debt increases substantiallyKeryx Biopharmaceuticals has witnessed an increase in total debt over the last one year. It stood at $125 million as on Dec. 31, 2016, up 37.71 percent or $34.23 million from $90.77 million on Dec. 31, 2015. Total debt was 88.38 percent of total assets as on Dec. 31, 2016, compared with 35.09 percent on Dec. 31, 2015.      Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: [email protected]



 Post Comment
Name Email
Comment
Security Code type    into this box
US Equities
Innodata Isogen swings to first-quarter loss on a YOY basis - 10-Jul-2017 03:29
Echelon Corp first-quarter loss widens on a YOY basis - 09-Jul-2017 20:32
Diversicare Healthcare Services swings to first-quarter profit on a YOY basis - 09-Jul-2017 19:51
Dextera Surgical third-quarter loss widens on a YOY basis - 09-Jul-2017 18:20
Open Text Corp third-quarter earnings plunge by 68.72 percent on a YOY basis - 09-Jul-2017 15:17
NAPCO Security Technologies third-quarter earnings decline by 12.19 percent on a YOY basis - 09-Jul-2017 14:31
Patriot National Bancorp first-quarter profit jumps 165.75 percent on a YOY basis - 09-Jul-2017 13:29
Patriot National Bancorp first-quarter profit jumps 165.75 percent on a YOY basis - 09-Jul-2017 13:29
Alaska Communications Systems Group swings to first-quarter loss on a YOY basis - 09-Jul-2017 12:00
Delcath Systems first-quarter loss widens on a YOY basis - 08-Jul-2017 18:33
Edgewater Technology first-quarter loss widens on a YOY basis - 08-Jul-2017 16:21
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer